Lv1
10 积分 2023-12-13 加入
CD70 as a therapeutic target in human malignancies
2天前
已完结
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
7天前
已完结
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial
3个月前
已完结
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial
3个月前
已完结
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial
3个月前
已完结
Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications
7个月前
已完结
Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications
7个月前
已完结
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells
7个月前
已完结
Perioperative treatment strategies in EGFR-mutant early-stage NSCLC: current evidence and future challenges
9个月前
已完结
皖公网安备34019202002308
